Tuesday, 16 October 2018
Wednesday, 10 October 2018
Monday, 8 October 2018
Parliament gives green light on Health Technology Assessment
On the 3rd of October, the European Parliament voted on
the report on Health Technology Assessment (HTA), under the leadership of S&D MEP Soledad Cabézon Ruiz,
with a majority of MEPs approving the European Commission’s proposal (576 in
favour, 56 against) which vows to introduce a joint clinical assessment of
health technologies at EU level. The plenary backed an amendment from the
European People’s Party that would change the threshold for decisions in the
Coordination Group from a two-thirds majority to a qualified majority.
The proposal covers new medicines
and certain medical devices, and would provide the basis for permanent EU-level
cooperation in four areas: joint clinical assessments; joint scientific
consultations; identification of emerging health technologies; and voluntary
cooperation on other aspects of HTA.
All in one, HTA is a
research-based tool that focuses specifically on the added therapeutic value of
a health technology in comparison with other health technologies. Yet, there
are challenges to tackle. Due to the large heterogeneity of the methodologies
used across practices and Member States, it is very difficult to obtain a
consolidated opinion from a HTA. On the other hand, a number of advantages is
unparalleled, such as faster and more efficient drug development, tackling rare
diseases and allowing to answer multiple research questions in parallel.
How does the Commission envisage
HTA implementation?
Overall, the cooperation would be
Member State driven, with the Commission hosting a secretariat to provide administrative,
scientific and IT support. Participation in the joint clinical assessments and
use of the joint clinical assessment reports at Member State level would become
mandatory after six years: following the regulation’s entry into force, the
Commission proposes a three-year period for adopting tertiary legislation and
another three year (transitional) period to allow Member States to fully adapt
to the new system.
Next steps?
We now wish to call upon EU
policymakers to initiate trilogue inter-institutional negotiations without
delay, in view of reaching a final agreement ahead of the European elections in
2019. In the case of no position adopted before the upcoming elections, next
May, a new parliamentary position may have to be developed and adopted.
Additionally, the reluctance of a
number of Member States may come as a hurdle too. Countries like Germany,
France, Poland and Czech Republic can block the proposal in the Council of the
EU, compromising reached amendments.
Subscribe to:
Posts (Atom)